Delineation of organs at risk.

{"article_title":"Delineation of organs at risk.","author":"No\u00ebl G, Le F\u00e8vre C, Antoni D","journal_title":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique","issn":"1769-6658","isbn":"","publication_date":"2022-02-01","volume":"26","issue":"1-Feb","first_page":"76","page_count":"","accession_number":"34862133","doi":"10.1016\/j.canrad.2021.08.001","publisher":"Elsevier","doctype":"Journal Article","subjects":"France; Organs at Risk diagnostic imaging; France; Humans; Organs at Risk anatomy & histology; Organs at Risk radiation effects; Radiation Oncology; Radiation Tolerance; Re-Irradiation methods; Societies, Medical","interest_area":["Emergency Medicine"],"abstract":"The delineation of organs at risk is the basis of radiotherapy oncologists' work. Indeed, the knowledge of this delineation enables to better identify the target volumes and to optimize dose distribution, involving the prognosis of the patients but also their future. The learning of this delineation must continue throughout the clinician's career. Some contour changes have appeared with better imaging, some volumes are now required due to development of knowledge of side effects. In addition, the increasing survival time of patients requires to be more systematic and precise in the delineations, both to avoid complications until now exceptional but also because re-irradiations are becoming more and more frequent. We present the update of the recommendations of the French Society for Radiation Oncology (SFRO) on new findings or adaptations to volumes at risk. Copyright \u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=34862133","isPdfLink":false,"isSAML":false,"an":"34862133","number_other":"","type_pub":"","issn_electronic":"1769-6658","languages":"English","language":"eng","date_entry":"Date Created: 20211204 Date Completed: 20220217 Latest Revision: 20220217","date_update":"20240105","titleSource":"Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2022 Feb-Apr; Vol. 26 (1-2), pp. 76-91. Date of Electronic Publication: 2021 Nov 30.","date_pub_cy":"","type_document":"","contract_publisher":"","authored_on":"2022-02-01","description":"The delineation of organs at risk is the basis of radiotherapy oncologists' work. Indeed, the knowledge of this delineation enables to better identify the target volumes and to optimize dose distribution, involving the prognosis of the patients but also their future. The learning of this delineation must continue throughout the clinician's career. Some contour changes have appeared with better imaging, some volumes are now required due to development of knowledge of side effects. In addition, the increasing survival time of patients requires to be more systematic and precise in the delineations, both to avoid complications until now exceptional but also because re-irradiations are becoming more and more frequent. We present the update of the recommendations of the French Society for Radiation Oncology (SFRO) on new findings or adaptations to volumes at risk.<br \/> (Copyright © 2021 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.)","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&scope=site&db=mdl&AN=34862133&authtype=shib&custid=ns346513&group=main&profile=eds","no_of_pages":"","authored_by":"No\u00ebl G, Le F\u00e8vre C, Antoni D"}